FAST vs HAE · P/E 43, rev $7.55B vs P/E 35, rev $1.36B
Fastenal Company (FAST) versus Haemonetics Corporation (HAE) — a side-by-side from cached financials, not a winner call.
Fastenal Company (FAST) is a industrial distribution company listed on US.
Haemonetics Corporation (HAE) is a medical devices company listed on US.
Latest reported FAST revenue for 2024-12-31 was $7.55B. Net income was $1.15B. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
Latest reported HAE revenue for 2025-03-29 was $1.36B. Net income was $167.7M. Revenue was up 4.0% from 2024-03-30 to 2025-03-29. HAE currently screens at market cap $3.24B and trailing P/E 34.8.
FAST currently screens at market cap $49.48B and trailing P/E 43.1. HAE currently screens at market cap $3.24B and trailing P/E 34.8.
Not investment advice. Open the FAST and HAE stock pages for the full models.
Not investment advice.